646 related articles for article (PubMed ID: 8843179)
1. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
2. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor (PAI-1) and non-insulin-dependent diabetes in Pima Indians, south Asians and Europeans. Populations at varying risk of NIDDM and coronary artery disease.
Nagi DK; Knowler WC; Hanson RL; Ali VM; Yudkin JS
Thromb Haemost; 1996 Jun; 75(6):921-7. PubMed ID: 8822587
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians.
Nagi DK; Foy CA; Mohamed-Ali V; Yudkin JS; Grant PJ; Knowler WC
Metabolism; 1998 May; 47(5):622-6. PubMed ID: 9591757
[TBL] [Abstract][Full Text] [Related]
5. Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.
Nagi DK; Knowler WC; Mohamed-Ali V; Bennett PH; Yudkin JS
Diabetes Care; 1998 Jan; 21(1):127-33. PubMed ID: 9538983
[TBL] [Abstract][Full Text] [Related]
6. Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight.
Stefan N; Weyer C; Levy-Marchal C; Stumvoll M; Knowler WC; Tataranni PA; Bogardus C; Pratley RE
Metabolism; 2004 Jul; 53(7):904-11. PubMed ID: 15254885
[TBL] [Abstract][Full Text] [Related]
7. Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.
Weyer C; Tataranni PA; Pratley RE
Diabetes Care; 2000 Jun; 23(6):779-85. PubMed ID: 10840996
[TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.
Nagi DK; McCormack LJ; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
Diabetes Care; 1997 Aug; 20(8):1304-9. PubMed ID: 9250459
[TBL] [Abstract][Full Text] [Related]
9. Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents.
Gulli G; Rossetti L; DeFronzo RA
Metabolism; 1997 Oct; 46(10):1157-61. PubMed ID: 9322799
[TBL] [Abstract][Full Text] [Related]
10. Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians.
Paolisso G; Ravussin E
J Clin Endocrinol Metab; 1995 Apr; 80(4):1382-5. PubMed ID: 7714114
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
Koistinen HA; Dusserre E; Ebeling P; Vallier P; Koivisto VA; Vidal H
Diabetes Metab Res Rev; 2000; 16(5):364-9. PubMed ID: 11025560
[TBL] [Abstract][Full Text] [Related]
12. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.
Vozarova de Courten B; Degawa-Yamauchi M; Considine RV; Tataranni PA
Diabetes; 2004 May; 53(5):1279-84. PubMed ID: 15111497
[TBL] [Abstract][Full Text] [Related]
13. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.
Potter van Loon BJ; Kluft C; Radder JK; Blankenstein MA; Meinders AE
Metabolism; 1993 Aug; 42(8):945-9. PubMed ID: 8345817
[TBL] [Abstract][Full Text] [Related]
14. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
Bastard JP; Bruckert E; Robert JJ; Ankri A; Grimaldi A; Jardel C; Hainque B
Int J Obes Relat Metab Disord; 1995 Nov; 19(11):836-8. PubMed ID: 8589788
[TBL] [Abstract][Full Text] [Related]
15. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
Koopmans SJ; Kushwaha RS; DeFronzo RA
Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.
Stefan N; Kovacs P; Stumvoll M; Hanson RL; Lehn-Stefan A; Permana PA; Baier LJ; Tataranni PA; Silver K; Bogardus C
Diabetes; 2003 Jun; 52(6):1544-50. PubMed ID: 12765968
[TBL] [Abstract][Full Text] [Related]
17. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians.
Pratley RE; Nicolson M; Bogardus C; Ravussin E
J Clin Endocrinol Metab; 1996 Dec; 81(12):4418-21. PubMed ID: 8954052
[TBL] [Abstract][Full Text] [Related]
18. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Vozarova B; Stefan N; Lindsay RS; Saremi A; Pratley RE; Bogardus C; Tataranni PA
Diabetes; 2002 Jun; 51(6):1889-95. PubMed ID: 12031978
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an early decline in baseline plasma glucose concentration after acute insulin elevation during euglycemic hyperinsulinemic clamp in patients with type 2 diabetes mellitus.
Wasada T; Kuroki H; Arii H; Sato A; Katsumori K; Saito S; Iwamoto Y
Endocr J; 2000 Jun; 47(3):309-16. PubMed ID: 11036875
[TBL] [Abstract][Full Text] [Related]
20. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
